Codes / ICD10CM / C83.58

C83.58 Lymphoblastic (diffuse) lymphoma, lymph nodes of multiple sites

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Lymphoblastic (diffuse) lymphoma, lymph nodes of multiple sites

Summary

Lymphoblastic (diffuse) lymphoma is a type of non-Hodgkin lymphoma characterized by the rapid proliferation of immature lymphoid cells. It typically affects lymph nodes or other lymphoid tissues and may involve B-cells or T-cells. The "lymph nodes of multiple sites" designation indicates the condition is documented with involvement of lymph nodes in more than one anatomical region.

Causes

The exact cause of lymphoblastic (diffuse) lymphoma is unknown. It is believed to involve genetic mutations or abnormalities in lymphoid cell development, though specific triggers are not well-defined. Research suggests potential links to immune system dysregulation, but no definitive etiology has been established.

Risk Factors

  • Age: More common in children and young adults.
  • Genetic predisposition or family history of lymphoma.
  • Prior exposure to radiation or certain chemicals.
  • Immunosuppressive conditions or treatments.

Symptoms

  • Swollen, painless lymph nodes.
  • Unexplained weight loss.
  • Fever.
  • Night sweats.
  • Fatigue.
  • Loss of appetite.

Diagnosis

Diagnosis involves a combination of physical examination, imaging tests (e.g., CT or PET scans) to identify affected areas, biopsy of lymph nodes or tissues for laboratory analysis, and blood tests to assess overall health and detect abnormal cell markers.

Treatment Options

  • Chemotherapy: Systemic drugs to target rapidly dividing cells.
  • Radiation therapy: Localized treatment to reduce tumor size or control symptoms.
  • Immunotherapy: Therapies that enhance the immune system's ability to fight cancer.
  • Stem cell transplant: For eligible patients, particularly in advanced or relapsed cases.

Prognosis and Follow-Up

Prognosis depends on factors such as age, overall health, and response to treatment. Regular follow-up appointments are essential to monitor for recurrence or complications. Long-term surveillance may include imaging and blood tests.

Complications

  • Recurrence of lymphoma.
  • Infection due to weakened immune system.
  • Side effects from treatment (e.g., fatigue, nausea, organ toxicity).
  • Potential transformation to a more aggressive lymphoma type.

Lifestyle & Prevention

  • Maintain a balanced diet to support overall health.
  • Avoid known carcinogens (e.g., tobacco, excessive alcohol).
  • Practice good hygiene to reduce infection risk.
  • Stay up-to-date with vaccinations as recommended by a healthcare provider.

When to Seek Professional Help

Seek medical attention if you experience persistent swollen lymph nodes, unexplained weight loss, fever, or other concerning symptoms. Prompt evaluation is important for early diagnosis and treatment.

Tips for Medical Coders

When coding C83.58, ensure documentation specifies involvement of lymph nodes in multiple sites. Verify that the diagnosis aligns with the clinical presentation and that no more specific site code applies. Accurate coding requires clear documentation of the anatomical regions affected.

Book a walkthrough

C83.58 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.